Fiscal year 2024 total revenues of $475.4
million, up 13% year-over-year Fiscal year 2024 net income growth
of 31% and adjusted EBITDA growth of 25% year-over-year
Q4 total revenues of $118.1 million, up 6%
year-over-year Q4 net income growth of 32% and adjusted EBITDA
growth of 15% year-over-year
Doximity, Inc. (NYSE: DOCS), the leading digital platform for
U.S. medical professionals, today announced results of its fiscal
2024 fourth quarter and fiscal year ended March 31, 2024.
“We were pleased to beat on our top and bottom lines, as we
delivered another quarter of strong profits and record engagement,”
said Jeff Tangney, co-founder and CEO of Doximity. “We’re proud to
bring AI and automation to clinical workflows, with over 580,000
unique providers using our workflow tools last quarter.”
Fiscal 2024 Fourth Quarter Financial Highlights
All comparisons, unless otherwise noted, are to the three months
ended March 31, 2023.
- Revenue: Revenue of $118.1 million, versus $111.0
million, an increase of 6% year-over-year. Subscription revenue of
$112.7 million, versus $103.2 million, an increase of 9%
year-over-year.
- Net income and non-GAAP net income: Net income of $40.6
million, versus $30.7 million, representing a margin of 34.4%,
versus 27.6%. Non-GAAP net income of $51.0 million, versus $42.1
million, representing a margin of 43.2%, versus 38.0%.
- Adjusted EBITDA: Adjusted EBITDA of $56.4 million,
versus $48.9 million, an increase of 15% year-over-year,
representing adjusted EBITDA margins of 47.8%, versus 44.1%.
- Diluted net income per share and non-GAAP diluted net income
per share: Diluted net income per share was $0.20, versus
$0.14, while non-GAAP diluted net income per share was $0.25,
versus $0.20.
- Operating cash flow and free cash flow: Operating
cash flow of $63.9 million, versus $46.6 million, an increase of
37% year-over-year, and free cash flow of $62.3 million, versus
$45.6 million, an increase of 37% year-over-year.
Fiscal Year 2024 Financial Highlights
All comparisons, unless otherwise noted, are to the fiscal year
ended March 31, 2023.
- Revenue: Revenue of $475.4 million, versus $419.1
million, an increase of 13% year-over-year. Subscription revenue of
$450.1 million, versus $389.7 million, an increase of 15%
year-over-year.
- Net income and non-GAAP net income: Net income of $147.6
million, versus $112.8 million, representing a margin of 31.0%,
versus 26.9%. Non-GAAP net income of $195.6 million, versus $154.9
million, representing a margin of 41.2%, versus 37.0%.
- Adjusted EBITDA: Adjusted EBITDA of $230.5 million,
versus $184.0 million, an increase of 25% year-over-year,
representing adjusted EBITDA margins of 48.5%, versus 43.9%.
- Diluted net income per share and non-GAAP diluted net income
per share: Diluted net income per share was $0.72, versus
$0.53, while non-GAAP diluted net income per share was $0.95,
versus $0.73.
- Operating cash flow and free cash flow: Operating
cash flow of $184.1 million, versus $179.6 million, an increase of
3% year-over-year, and free cash flow of $178.3 million, versus
$173.4 million, an increase of 3% year-over-year.
Financial Outlook
Doximity is providing guidance for its fiscal first quarter
ending June 30, 2024 as follows:
- Revenue between $119.5 million and $120.5 million.
- Adjusted EBITDA between $55 million and $56 million.
Doximity is providing guidance for its fiscal year ending March
31, 2025 as follows:
- Revenue between $506 million and $518 million.
- Adjusted EBITDA between $238 million and $250 million.
Stock Repurchase Program
On May 1, 2024 the Company’s board of directors authorized a
program to repurchase up to $500 million of the Company’s Class A
common stock. The repurchase program has no expiration date and is
subject to general business and market conditions and other
investment opportunities, through open market purchases or
privately negotiated transactions, including through Rule 10b5-1
plans. Immediately upon the repurchase of any shares of Class A
common stock, such shares shall be retired by the Company and shall
automatically return to the status of authorized but unissued
shares of Class A common stock. All prior repurchase programs were
completed as of April 2024.
Conference Call Information
Doximity posted prepared remarks on its investor relations
website at https://investors.doximity.com. Doximity will host a
webcast today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to
discuss these financial results. To listen to a live audio webcast,
please visit the Company’s Investor Relations page at
https://investors.doximity.com. The archived webcast will be
available on the Company’s Investor Relations page shortly after
the call.
About Doximity
Founded in 2010, Doximity is the leading digital platform for
U.S. medical professionals. The company's network members include
more than 80% of U.S. physicians across all specialties and
practice areas. Doximity provides its verified clinical membership
with digital tools built for medicine, enabling them to collaborate
with colleagues, stay up to date with the latest medical news and
research, manage their careers and on-call schedules, streamline
documentation and administrative paperwork, and conduct virtual
patient visits. Doximity's mission is to help doctors be more
productive so they can provide better care for their patients.
Forward-Looking Statements
Statements we make in this press release may include statements
which are not historical facts and are considered forward-looking
within the meaning of Section 27A of the Securities Act and Section
21E of the Securities Exchange Act, which are usually identified by
the use of words such as “anticipates,” “believes,” “estimates,”
“expects,” “intends,” “may,” “plans,” “projects,” “seeks,”
“should,” “will,” and variations of such words or similar
expressions. We intend these forward-looking statements to be
covered by the safe harbor provisions for forward-looking
statements contained in Section 27A of the Securities Act and
Section 21E of the Securities Exchange Act and are making this
statement for purposes of complying with those safe harbor
provisions. These forward-looking statements reflect our current
views about our plans, intentions, expectations, strategies and
prospects, which are based on the information currently available
to us and on assumptions we have made. Although we believe that our
plans, intentions, expectations, strategies and prospects as
reflected in or suggested by those forward-looking statements are
reasonable, we can give no assurance that the plans, intentions,
expectations, or strategies will be attained or achieved.
Furthermore, actual results may differ materially from those
described in the forward-looking statements and will be affected by
a variety of risks and factors including (i) the timing and scope
of anticipated stock repurchases; (ii) the impact of uncertainty in
the current economic environment and macroeconomic uncertainty;
(iii) our ability to retain existing members or add new members to
our platform and maintain or grow their engagement with our
platform; (iv) our ability to attract new customers or retain
existing customers; (v) the impact of our prioritization of our
members’ interests; (vi) breaches in our security measures or
unauthorized access to members’ data; (vii) our ability to maintain
or manage our growth, and other risks and factors that are beyond
our control including, without limitation, those set forth in the
section entitled “Risk Factors” in the Quarterly Report on Form
10-Q for the fiscal quarter ended December 31, 2023. Additional
information will be provided in our Annual Report on Form 10-K for
the fiscal year ended March 31, 2024. Moreover, we operate in a
very competitive and rapidly changing environment. New risks and
uncertainties emerge from time to time, and it is not possible for
us to predict all risks and uncertainties that could cause actual
results to differ materially from those contained in our
forward-looking statements. The forward-looking statements made in
this press release relate only to management’s beliefs and
assumptions as of this date. We assume no obligation to update
publicly any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by
law.
DOXIMITY, INC.
CONSOLIDATED BALANCE
SHEETS
(in thousands)
(unaudited)
March 31, 2024
March 31, 2023
Assets
Current assets:
Cash and cash equivalents
$
96,785
$
158,027
Marketable securities
666,115
682,972
Accounts receivable, net
101,332
107,047
Prepaid expenses and other current
assets
48,709
27,407
Total current assets
912,941
975,453
Property and equipment, net
12,318
11,279
Deferred income tax assets
45,068
34,907
Operating lease right-of-use assets
12,332
13,819
Intangible assets, net
27,317
31,836
Goodwill
67,940
67,940
Other assets
1,458
1,654
Total assets
$
1,079,374
$
1,136,888
Liabilities and Stockholders’
Equity
Current liabilities:
Accounts payable
$
2,253
$
1,272
Accrued expenses and other current
liabilities
43,703
31,245
Deferred revenue, current
99,145
105,238
Operating lease liabilities, current
2,149
1,752
Total current liabilities
147,250
139,507
Deferred revenue, non-current
211
198
Operating lease liabilities,
non-current
12,397
13,885
Contingent earn-out consideration
liability, non-current
10,895
15,942
Other liabilities, non-current
7,224
1,240
Total liabilities
177,977
170,772
Stockholders' Equity
Preferred stock
—
—
Common stock
187
194
Additional paid-in capital
823,885
762,150
Accumulated other comprehensive loss
(2,664
)
(14,083
)
Retained earnings
79,989
217,855
Total stockholders' equity
901,397
966,116
Total liabilities and stockholders’
equity
$
1,079,374
$
1,136,888
DOXIMITY, INC.
CONSOLIDATED STATEMENTS OF
OPERATIONS
(in thousands, except per
share data)
(unaudited)
Three Months Ended March
31,
Fiscal Year Ended March
31,
2024
2023
2024
2023
Revenue
$
118,057
$
110,966
$
475,422
$
419,052
Cost of revenue(1)
12,567
13,677
50,669
53,490
Gross profit
105,490
97,289
424,753
365,562
Operating expenses(1):
Research and development
20,148
21,541
81,983
80,186
Sales and marketing
33,517
33,148
133,129
123,523
General and administrative
9,973
9,759
37,827
36,745
Restructuring
—
—
7,936
—
Total operating expenses
63,638
64,448
260,875
240,454
Income from operations
41,852
32,841
163,878
125,108
Other income, net
6,101
3,875
21,324
8,048
Income before income taxes
47,953
36,716
185,202
133,156
Provision for income taxes
7,335
6,048
37,620
20,338
Net income
$
40,618
$
30,668
$
147,582
$
112,818
Net income per share attributable to Class
A and Class B common stockholders:
Basic
$
0.22
$
0.16
$
0.78
$
0.58
Diluted
$
0.20
$
0.14
$
0.72
$
0.53
Weighted-average shares used in computing
net income per share attributable to Class A and Class B common
stockholders:
Basic
186,756
193,829
190,172
193,176
Diluted
201,110
212,742
205,734
213,425
(1) Costs and expenses include stock-based
compensation expense as follows (in thousands):
Three Months Ended March
31,
Fiscal Year Ended March
31,
2024
2023
2024
2023
Cost of revenue
$
2,274
$
2,425
$
9,479
$
9,634
Research and development
3,104
3,167
11,978
12,583
Sales and marketing
4,105
5,027
16,857
16,939
General and administrative
2,374
2,372
9,116
8,678
Restructuring
—
—
3,646
—
Total stock-based compensation expense
$
11,857
$
12,991
$
51,076
$
47,834
DOXIMITY, INC.
CONSOLIDATED STATEMENTS OF
CASH FLOWS
(in thousands)
(unaudited)
Three Months Ended March
31,
Fiscal Year Ended March
31,
2024
2023
2024
2023
Cash flows from operating
activities
Net income
$
40,618
$
30,668
$
147,582
$
112,818
Adjustments to reconcile net income to net
cash provided by operating activities:
Depreciation and amortization
2,548
2,708
10,265
10,283
Deferred income taxes
(8,593
)
3,834
(8,593
)
13,226
Stock-based compensation, net of amounts
capitalized
11,857
12,991
51,076
47,834
Non-cash lease expense
475
537
2,074
2,027
Amortization of premium (accretion of
discount) on marketable securities, net
(1,761
)
(29
)
(5,238
)
3,115
Net loss on sale of marketable
securities
—
—
402
1,093
Amortization of deferred contract
costs
2,593
2,428
8,871
8,785
Change in fair value of contingent
earn-out consideration liability
183
405
951
728
Other
773
252
1,230
726
Changes in operating assets and
liabilities, net of effect of acquisition:
Accounts receivable
(4,516
)
(32,433
)
3,993
(26,242
)
Prepaid expenses and other assets
(16,502
)
(5,372
)
(20,483
)
(3,448
)
Deferred contract costs
(1,683
)
(2,053
)
(8,608
)
(8,462
)
Accounts payable, accrued expenses and
other liabilities
5,966
(2,918
)
8,332
(195
)
Deferred revenue
32,496
35,625
(6,080
)
17,527
Operating lease liabilities
(510
)
(4
)
(1,678
)
(213
)
Net cash provided by operating
activities
63,944
46,639
184,096
179,602
Cash flows from investing
activities
Cash paid for acquisition
—
—
—
(53,500
)
Purchases of property and equipment
—
(21
)
(147
)
(1,701
)
Internal-use software development
costs
(1,634
)
(1,005
)
(5,654
)
(4,483
)
Purchases of marketable securities
(191,529
)
(60,303
)
(472,867
)
(190,560
)
Maturities of marketable securities
116,993
48,125
435,179
83,139
Sales of marketable securities
—
—
74,675
107,182
Net cash provided by (used in)
investing activities
(76,170
)
(13,204
)
31,186
(59,923
)
Cash flows from financing
activities
Proceeds from issuance of common stock
upon exercise of stock options and common stock warrants
3,134
2,471
12,892
9,926
Proceeds from issuance of common stock in
connection with the employee stock purchase plan
1,952
2,418
3,446
4,759
Taxes paid related to net share settlement
of equity awards
(1,424
)
(1,469
)
(6,756
)
(3,822
)
Repurchase of common stock
(17,740
)
(15,282
)
(280,716
)
(85,324
)
Payment of contingent consideration
related to a business combination
—
—
(5,390
)
—
Net cash used in financing
activities
(14,078
)
(11,862
)
(276,524
)
(74,461
)
Net increase (decrease) in cash and cash
equivalents
(26,304
)
21,573
(61,242
)
45,218
Cash and cash equivalents, beginning of
period
123,089
136,454
158,027
112,809
Cash and cash equivalents, end of
period
$
96,785
$
158,027
$
96,785
$
158,027
Supplemental disclosures of cash flow
information
Cash paid for taxes, net of refunds
$
12,911
$
2,727
$
51,274
$
5,231
Non-GAAP Financial Measures
To supplement our consolidated financial statements, which are
prepared and presented in accordance with accounting principles
generally accepted in the United States (“GAAP”), the Company uses
the following non-GAAP measures of financial performance:
- Non-GAAP gross profit, non-GAAP gross margin, non-GAAP
operating income, non-GAAP net income, non-GAAP net income margin,
and non-GAAP basic and diluted net income per common share: We
exclude the effect of stock-based compensation expense,
amortization of acquired intangible assets, restructuring expense,
change in fair value of contingent earn-out consideration
liability, and acquisition and other related expenses from non-GAAP
gross profit, non-GAAP gross margin and non-GAAP operating income.
Non-GAAP net income and non-GAAP net income margin are further
adjusted for estimated income tax on such adjustments. We calculate
income taxes on the adjustments by applying an estimated annual
effective tax rate to the adjustments. Non-GAAP basic and diluted
net income per common share is non-GAAP net income attributable to
common stockholders divided by the weighted average number of
shares. For both basic and diluted non-GAAP net income per share,
the weighted average shares we use in computing non-GAAP net income
per share is equal to our GAAP weighted average shares. Non-GAAP
gross margin represents non-GAAP gross profit as a percentage of
revenue and non-GAAP net income margin represents non-GAAP net
income as a percentage of revenue.
- Adjusted EBITDA and adjusted EBITDA margin: We define
adjusted EBITDA as net income before interest, income taxes,
depreciation, and amortization, and as further adjusted for
acquisition and other related expenses, stock-based compensation
expense, restructuring expense, change in fair value of contingent
earn-out consideration liability, and other income, net. Net income
margin represents net income as a percentage of revenue and
adjusted EBITDA margin represents adjusted EBITDA as a percentage
of revenue.
- Free cash flow: We calculate free cash flow as cash flow
from operating activities less purchases of property and equipment
and internal-use software development costs.
We use these non-GAAP financial measures internally for
financial and operational decision-making purposes and as a means
to evaluate period-to-period comparisons. Non-GAAP financial
measures are not meant to be considered in isolation or as a
substitute for comparable GAAP financial measures and should be
read only in conjunction with our consolidated financial statements
prepared in accordance with GAAP. Our presentation of non-GAAP
financial measures may not be comparable to similar measures used
by other companies. We encourage investors to carefully consider
our results under GAAP, as well as our supplemental non-GAAP
information and the reconciliation between these presentations, to
more fully understand our business. Please see the tables included
at the end of this release for the reconciliation of GAAP to
non-GAAP results.
Key Business Metrics
- Net revenue retention rate: Net revenue retention rate
is calculated by taking the trailing 12-month (“TTM”)
subscription-based revenue from our customers that had revenue in
the prior TTM period and dividing that by the total
subscription-based revenue for the prior TTM period. For the
purposes of this calculation, subscription revenue excludes
subscriptions for individuals and small practices and other
non-recurring items. Our net revenue retention rate compares our
subscription revenue from the same set of customers across
comparable periods, and reflects customer renewals, expansion,
contraction, and churn. Our net revenue retention rate is directly
tied to our revenue growth rate and thus fluctuates as that growth
rate fluctuates.
- Customers with trailing 12-month subscription revenue
greater than $100,000 and $500,000: The number of customers
with TTM subscription revenue greater than $100,000 and $500,000 is
a key indicator of the scale of our business, and is calculated by
counting the number of customers that contributed more than
$100,000 and $500,000 in subscription revenue in the TTM period.
Our customer count is subject to adjustments for acquisitions,
consolidations, spin-offs, and other market activity, and we
present our total customer count for historical periods reflecting
these adjustments.
Reconciliation of GAAP to Non-GAAP Financial Measures
The following tables reconcile the specific items excluded from
GAAP metrics in the calculation of non-GAAP metrics for the periods
shown below:
Three Months Ended March
31,
Fiscal Year Ended March
31,
2024
2023
2024
2023
(unaudited)
(in thousands, except
percentages)
Net income
$
40,618
$
30,668
$
147,582
$
112,818
Adjusted to exclude the following:
Acquisition and other related expenses
—
—
—
30
Stock-based compensation
11,857
12,991
47,430
47,834
Depreciation and amortization
2,548
2,708
10,265
10,283
Provision for income taxes
7,335
6,048
37,620
20,338
Restructuring expense
—
—
7,936
—
Change in fair value of contingent
earn-out consideration liability
183
405
951
728
Other income, net
(6,101
)
(3,875
)
(21,324
)
(8,048
)
Adjusted EBITDA
$
56,440
$
48,945
$
230,460
$
183,983
Revenue
$
118,057
$
110,966
$
475,422
$
419,052
Net income margin
34.4
%
27.6
%
31.0
%
26.9
%
Adjusted EBITDA margin
47.8
%
44.1
%
48.5
%
43.9
%
Three Months Ended March
31,
Fiscal Year Ended March
31,
2024
2023
2024
2023
(unaudited)
(in thousands)
Net cash provided by operating
activities
$
63,944
$
46,639
$
184,096
$
179,602
Purchases of property and equipment
—
(21
)
(147
)
(1,701
)
Internal-use software development
costs
(1,634
)
(1,005
)
(5,654
)
(4,483
)
Free cash flow
$
62,310
$
45,613
$
178,295
$
173,418
Other cash flow components:
Net cash provided by (used in) investing
activities
$
(76,170
)
$
(13,204
)
$
31,186
$
(59,923
)
Net cash used in financing activities
$
(14,078
)
$
(11,862
)
$
(276,524
)
$
(74,461
)
Three Months Ended March
31,
Fiscal Year Ended March
31,
2024
2023
2024
2023
(unaudited)
(in thousands, except per
share data and percentages)
GAAP cost of revenue
$
12,567
$
13,677
$
50,669
$
53,490
Adjusted to exclude the following:
Stock-based compensation
(2,274
)
(2,425
)
(9,479
)
(9,634
)
Amortization of acquired intangibles
—
(137
)
(274
)
(548
)
Non-GAAP cost of revenue
$
10,293
$
11,115
$
40,916
$
43,308
GAAP gross profit
$
105,490
$
97,289
$
424,753
$
365,562
Adjusted to exclude the following:
Stock-based compensation
2,274
2,425
9,479
9,634
Amortization of acquired intangibles
—
137
274
548
Non-GAAP gross profit
$
107,764
$
99,851
$
434,506
$
375,744
GAAP gross margin
89.4
%
87.7
%
89.3
%
87.2
%
Non-GAAP gross margin
91.3
%
90.0
%
91.4
%
89.7
%
GAAP research and development expense
$
20,148
$
21,541
$
81,983
$
80,186
Adjusted to exclude the following:
Stock-based compensation
(3,104
)
(3,167
)
(11,978
)
(12,583
)
Non-GAAP research and development
expense
$
17,044
$
18,374
$
70,005
$
67,603
GAAP sales and marketing expense
$
33,517
$
33,148
$
133,129
$
123,523
Adjusted to exclude the following:
Stock-based compensation
(4,105
)
(5,027
)
(16,857
)
(16,939
)
Amortization of acquired intangibles
(1,061
)
(979
)
(4,244
)
(4,164
)
Change in fair value of contingent
earn-out consideration liability
(183
)
(405
)
(951
)
(728
)
Non-GAAP sales and marketing expense
$
28,168
$
26,737
$
111,077
$
101,692
GAAP general and administrative
expense
$
9,973
$
9,759
$
37,827
$
36,745
Adjusted to exclude the following:
Acquisition and other related expenses
—
—
—
(30
)
Stock-based compensation
(2,374
)
(2,372
)
(9,116
)
(8,678
)
Non-GAAP general and administrative
expense
$
7,599
$
7,387
$
28,711
$
28,037
GAAP operating expense
$
63,638
$
64,448
$
260,875
$
240,454
Adjusted to exclude the following:
Acquisition and other related expenses
—
—
—
(30
)
Stock-based compensation
(9,583
)
(10,566
)
(37,951
)
(38,200
)
Amortization of acquired intangibles
(1,061
)
(979
)
(4,244
)
(4,164
)
Change in fair value of contingent
earn-out consideration liability
(183
)
(405
)
(951
)
(728
)
Restructuring
—
—
(7,936
)
—
Non-GAAP operating expense
$
52,811
$
52,498
$
209,793
$
197,332
GAAP operating income
$
41,852
$
32,841
$
163,878
$
125,108
Adjusted to exclude the following:
Acquisition and other related expenses
—
—
—
30
Stock-based compensation
11,857
12,991
47,430
47,834
Amortization of acquired intangibles
1,061
1,116
4,518
4,712
Change in fair value of contingent
earn-out consideration liability
183
405
951
728
Restructuring
—
—
7,936
—
Non-GAAP operating income
$
54,953
$
47,353
$
224,713
$
178,412
GAAP net income
$
40,618
$
30,668
$
147,582
$
112,818
Adjusted to exclude the following:
Acquisition and other related expenses
—
—
—
30
Stock-based compensation
11,857
12,991
47,430
47,834
Amortization of acquired intangibles
1,061
1,116
4,518
4,712
Change in fair value of contingent
earn-out consideration liability
183
405
951
728
Restructuring
—
—
7,936
—
Income tax effect of non-GAAP adjustments
(1)
(2,751
)
(3,048
)
(12,775
)
(11,194
)
Non-GAAP net income
$
50,968
$
42,132
$
195,642
$
154,928
Non-GAAP net income margin
43.2
%
38.0
%
41.2
%
37.0
%
Weighted-average shares used in computing
net income per share attributable to Class A and Class B common
stockholders:
Basic
186,756
193,829
190,172
193,176
Diluted
201,110
212,742
205,734
213,425
Non-GAAP net income per share attributable
to Class A and Class B stockholders:
Basic
$
0.27
$
0.22
$
1.03
$
0.80
Diluted
$
0.25
$
0.20
$
0.95
$
0.73
(1)
For the three months and fiscal
years ended March 31, 2024 and 2023, management used an estimated
annual effective non-GAAP tax rate of 21.0%.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240516910294/en/
Investor Relations Contact: Perry Gold
ir@doximity.com
Media Contact: Amanda Cox pr@doximity.com
Doximity (NYSE:DOCS)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Doximity (NYSE:DOCS)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024